Sorafenib tosylate in advanced kidney cancer: past, present and future
Efficient activation of p53 pathway in A549 cells exposed to L2, a novel compound targeting p53–MDM2 interaction
The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells
Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation
Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells
Inhibition of functional HER family members increases the sensitivity to docetaxel in human ovarian cancer cell lines
New cytotoxic rosamine derivatives selectively accumulate in the mitochondria of cancer cells
Investigation of a new 1,3-diarylpropenone as a potential antimitotic agent targeting bladder carcinoma
Prevention of pancreatic cancer by the beta-blocker propranolol
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature
Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore
Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era
A phase I/II trial of fixed-dose docetaxel plus irinotecan and escalating doses of estramustine phosphate for second-line or greater treatment of selected advanced solid tumors
Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities
Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer
Apparent beneficial effects by nab-paclitaxel in the treatment of refractory metastatic ovarian carcinoma